(GERN)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
Geron Corporation, tijorat bosqichidagi biofarmatsevtika kompaniyasi, onkologiya uchun terapevtik mahsulotlarni ishlab chiqishga qaratilgan. Kompaniyaning mahsulotlar qatori quyidagilarni o'z ichiga oladi: RYTELO, transfuzion-bog'liq kamqonlik bilan past-dan o'rtacha-1 xavfli miyelodisplastik sindromlarga chalingan kattalar bemorlarni davolash uchun telomeraza inhibitori; IMerge, past xavfli miyelodisplastik sindromlarni davolash uchun 3-bosqich klinik sinovda; IMpactMF, qaytalangan/refrakter mielofibrozni davolash uchun 3-bosqichda; Impress, yuqori xavfli miyelodisplastik sindromlar va o'tkir miyeloid leykemiyani (OML) davolash uchun 2-bosqich klinik sinovda; IMproveMF, birinchi qator mielofibrozni davolash uchun 1-bosqich klinik sinovda; va IMAGINE, qaytalangan/refrakter OMLni davolash uchun 1/2-bosqich klinik sinovda. Geron Corporation 1990 yilda tashkil etilgan va Foster Siti, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joseph Emile Eid M.D. | Executive VP of Research & Development and Chief Medical Officer |
| Mr. Ahmed ElNawawi | Executive VP & Chief Commercial Officer |
| Mr. Bryan Ridgell | Senior VP of Portfolio & Project Management and Chief of Staff |
| Mr. Harout Semerjian | CEO, President & Director |
| Mr. Shanthakumar Tyavanagimatt | Senior VP & Chief Technical Officer |
| Ms. Aron Feingold | Vice President of Investor Relations & Corporate Communications |
| Ms. Dawn Schottlandt CFA | Senior Vice President of Investor Relations & Corporate Affairs |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-02 | S-3ASR | d118024ds3asr.htm |
| 2026-01-12 | 8-K | gern-20260112.htm |
| 2026-01-06 | 8-K | d88250d8k.htm |
| 2025-12-16 | 8-K | gern-20251210.htm |
| 2025-11-07 | 10-Q | gern-20250930.htm |
| 2025-11-05 | 8-K | gern-20251105.htm |
| 2025-10-14 | 8-K | gern-20251010.htm |
| 2025-08-06 | S-8 | s-8x2018inducementplanincr.htm |
| 2025-06-30 | S-8 | gern-sx8_june20252018eip20.htm |
| 2025-05-27 | 8-K | gern-20250521.htm |
| Ms. Michelle J. Robertson | Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer |
| Ms. Shannon T. Odam | Executive VP & Chief People Officer |